Getting Started with the Vue Financial Chart Component

Arun - Jun 17 '22 - - Dev Community

Learn how easily you can create and configure our Vue financial charts in a Vue app using Visual Studio Code. In this video, you will learn how to add high low, open high low close, and candle financial charts to a Vue app and how to enable some of their built-in features. You will also learn how these charts visually indicate stock price data elements like high, low, open, close, and volume.

Product overview: https://www.syncfusion.com/vue-ui-components/vue-charts

Explore our tutorial videos: https://www.syncfusion.com/tutorial-videos

Image
Peeling malady: connection to systemic diseases-the Maccabi glaucoma examine.
Image
Efficiency stableness look at atlas-based appliance learning radiotherapy therapy arranging inside cancer of prostate.
Image
Korzyści z prowadzenia sklepu internetowego w Holandii
Image
Find the Best Shared Hosting Services: Top 6 Picks for 2024
Image
Renal Infarction Imaged Together with [18F]Prostate-Specific Tissue layer Antigen-1007 PET/CT.
Image
The Effect of your Lively Breaks Plan in Major College Kids' Professional Features and also Emotive Intelligence.
Image
Do you Prefer to be Safe and sound reely? Mindset along with Behavioral Elements within COVID-19 Mitigation.
Image
The Best Products from Smart Energy Answers: Detailed Review
Image
Consult The Hack Angels for your Bitcoin recovery. 
Image
SydneySide Rubbish Removal: Your Trusted Partner for Waste Management

rubbish, rubbishremoval
Image
Herpes simplex virus Malware Increase the Probability of Alzheimer's Disease: Any Meta-Analysis.
Image
A Comprehensive Guide to Hiring Blockchain Developers from Vietnam for Singapore and US Businesses
Image
Using computer tongue image examination technologies inside the diagnosis of NAFLD.
Image
Heat Reactions involving Heterotrophic Microorganisms within Co-culture Using a Reddish Ocean Synechococcus Stress.
Image
Neonatal Atypical Hemolytic Uremic Affliction in the Eculizumab Age.
Image
Strain-Induced Modulation associated with Localized Surface area Plasmon Resonance in Ultrathin Hexagonal Gold Nanoplates.
Image
Heart-lung as opposed to. double-lung transplantation pertaining to idiopathic lung arterial high blood pressure.
Image
Pseudoexfoliation malady at a Singapore attention medical center.
Image
Collaborating with Other Musicians: Understanding the Benefits and Challenges with Daniel Siegel Loanso
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .